Ivax Research, Inc.

A RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, DOSE RANGING STUDY TO DETERMINE THE EFFICACY AND SAFETY OF AN INVESTIGATIONAL INTRANASAL CORTICOSTEROID COMPARED TO PLACEBO AND OPEN-LABEL FLUTICASONE PROPIONATE AQUEOUS NASAL SPRAY (FLIXONASE™) ADMINISTERED FOR 28 DAYS TO PATIENTS 4 to 11 YEARS OLD WITH PERENNIAL ALLERGIC RHINITIS - LENS Peds PAR Study